RESUMEN
BACKGROUND: Sensitization to Hymenoptera venom without systemic sting reactions (SSRs) is commonly observed in the general population. Clinical relevance for a future sting has not yet been investigated. OBJECTIVE: We aimed to evaluate the effect of these debatable sensitizations with deliberate sting challenges and to monitor serologic changes for up to 2 years. METHODS: One hundred thirty-one challenges with bees and wasps were performed in 94 subjects with a hitherto irrelevant sensitization. The clinical outcome was recorded, and results of specific IgE (sIgE) determinations, skin tests, and basophil activation tests were correlated to the sting reaction. sIgE levels were monitored in reactors and nonreactors after 3 hours, 1 week, 4 weeks, and 1 year. RESULTS: Only 5 (5.3%) patients had SSRs, but 41 (43.6%) had large local reactions (LLRs) after the sting. Compared with the general population, there was a 9.5-fold higher risk for LLRs but not for SSRs. Three hours after the sting, sIgE levels slightly decreased, but none of the 94 subjects' results turned negative. After 1 week, sIgE levels already increased, increasing up to 3.5-fold (range, 0.2- to 34.0-fold) baseline levels after 4 weeks. To assess the clinical relevance of this increase, we randomly selected 18 patients for a re-sting. Again, 50% had an LLR, but none had an SSR. CONCLUSION: Although sensitization to Hymenoptera venoms was common, the risk of SSRs in sensitized subjects was low in our study. The sIgE level increase after the sting was not an indicator for conversion into symptomatic sensitization. Currently available tests were not able to distinguish between asymptomatic sensitization, LLRs, and SSRs.
Asunto(s)
Alérgenos/inmunología , Venenos de Artrópodos/efectos adversos , Himenópteros/inmunología , Hipersensibilidad/inmunología , Mordeduras y Picaduras de Insectos/inmunología , Adulto , Animales , Femenino , Humanos , Hipersensibilidad/diagnóstico , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Mordeduras y Picaduras de Insectos/diagnóstico , Masculino , Evaluación del Resultado de la Atención al Paciente , Pruebas Cutáneas , Factores de Tiempo , Adulto JovenAsunto(s)
Alérgenos , Venenos de Artrópodos , Hialuronoglucosaminidasa , Hipersensibilidad/diagnóstico , Proteínas de Insectos , Alérgenos/inmunología , Animales , Venenos de Artrópodos/inmunología , Humanos , Hialuronoglucosaminidasa/inmunología , Himenópteros , Inmunoglobulina E/sangre , Proteínas de Insectos/inmunología , Mejoramiento de la Calidad , Reproducibilidad de los Resultados , Sensibilidad y EspecificidadAsunto(s)
Venenos de Abeja/inmunología , Hipersensibilidad Inmediata/diagnóstico , Inmunoglobulina E/inmunología , Proteínas de Insectos/inmunología , Venenos de Avispas/inmunología , Mordeduras y Picaduras , Reacciones Cruzadas , Humanos , Proteínas Recombinantes/inmunología , Proyectos de Investigación , Sensibilidad y EspecificidadRESUMEN
[This corrects the article DOI: 10.1186/s13601-016-0095-x.].
RESUMEN
BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Insect Venom Allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of insect venom allergy. METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised. DISCUSSION: The findings from this review will be used to inform the development of recomendations for EAACI's Guidelines on AIT.